Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1981 1
1987 1
1988 1
1991 1
1992 3
1993 1
1994 1
1996 1
1997 1
1998 5
1999 5
2000 1
2001 4
2002 7
2004 1
2005 3
2006 14
2007 26
2008 17
2009 26
2010 30
2011 45
2012 31
2013 37
2014 37
2015 44
2016 40
2017 42
2018 44
2019 45
2020 47
2021 67
2022 59
2023 55
2024 42
2025 51
2026 30

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

738 results

Results by year

Filters applied: . Clear all
Page 1
A phase Ib/2a study of fostrox in combination with lenvatinib as second line therapy in patients with advanced hepatocellular carcinoma.
Chon HJ, Heo J, Kim DY, Lim HY, Macarulla T, Gomez Martín C, Moreno V, Reig M, Ryu MH, Yoon JH, Baumann P, Bhoi S, Jensen M, Tunblad K, Wallberg H, Oberg F, Evans TRJ. Chon HJ, et al. Among authors: lim hy. Clin Cancer Res. 2026 Jun 9. doi: 10.1158/1078-0432.CCR-26-0273. Online ahead of print. Clin Cancer Res. 2026. PMID: 42262258
Cardiometabolic associations of SGLT-2 inhibitors on epicardial adiposity and left ventricular function in type 2 diabetes mellitus with coronary artery disease: insights from Malaysian EpiCAD study.
Mohamed WAS, Zaman Huri H, Mahmood Zuhdi AS, Sukahri S, Ishak KN, Mansor MN, Lim HY, Baharum N, Jaharudin AF, Zainudin NAZ, Rashed AA, Rosli N, Noh MFM, Abd Jamil AH. Mohamed WAS, et al. Among authors: lim hy. Sci Rep. 2026 May 15;16(1):22180. doi: 10.1038/s41598-026-53191-2. Sci Rep. 2026. PMID: 42141141 Free PMC article.
Early and late survival dynamics of immunotherapy combinations in advanced HCC: Anchored indirect comparison of atezolizumab plus bevacizumab versus durvalumab + tremelimumab.
Casadei-Gardini A, Yip TC, Vitale A, Rossari F, Tada T, Suda G, Shimose S, Kudo M, Cheon J, Finkelmeier F, Lim HY, Presa J, Masi G, Yoo C, Lonardi S, Piscaglia F, Kumada T, Scartozzi M, Tamburini E, Foschi FG, Camera S, Persano M, Pia D'Agata A, Ferrara M, Passeri L, Rimassa L, Rimini M. Casadei-Gardini A, et al. Among authors: lim hy. Eur J Cancer. 2026 Jun 3;240:116750. doi: 10.1016/j.ejca.2026.116750. Epub 2026 Apr 21. Eur J Cancer. 2026. PMID: 42068971
738 results